Literature DB >> 27998476

Idiopathic pulmonary fibrosis.

Antoni Xaubet1, Julio Ancochea2, María Molina-Molina3.   

Abstract

Idiopathic pulmonary fibrosis is a fibrosing interstitial pneumonia associated with the radiological and/or histological pattern of usual interstitial pneumonia. Its aetiology is unknown, but probably comprises the action of endogenous and exogenous micro-environmental factors in subjects with genetic predisposition. Its diagnosis is based on the presence of characteristic findings of high-resolution computed tomography scans and pulmonary biopsies in absence of interstitial lung diseases of other aetiologies. Its clinical evolution is variable, although the mean survival rate is 2-5 years as of its clinical presentation. Patients with idiopathic pulmonary fibrosis may present complications and comorbidities which modify the disease's clinical course and prognosis. In the mild-moderate disease, the treatment consists of the administration of anti-fibrotic drugs. In severe disease, the best therapeutic option is pulmonary transplantation. In this paper we review the diagnostic and therapeutic aspects of the disease.
Copyright © 2016 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Fibrosis pulmonar idiopática; Idiopathic pulmonary fibrosis; Interstitial pneumonia; Neumonía intersticial; Tratamiento; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27998476     DOI: 10.1016/j.medcli.2016.11.004

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  9 in total

1.  Clinical efficacy and quality of life effect of acetylcysteine plus pirfenidone in patients with pulmonary fibrosis.

Authors:  Rong Zhang; Zhanshuai Song; Yan Guan; Juan Zhang; Jianfang Zou; Yingxin Sun; Hua Shao
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation.

Authors:  Shanjun Yang; Wenwen Cui; Mingye Wang; Luming Xing; Yue Wang; Pengyu Zhu; Qisheng Qu; Qiang Tang
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-08       Impact factor: 2.629

3.  Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells.

Authors:  Yuan Hao; Samuel Bates; Hongmei Mou; Jeong H Yun; Betty Pham; Jiangyuan Liu; Weiliang Qiu; Feng Guo; Jarrett D Morrow; Craig P Hersh; Christopher J Benway; Lu Gong; Yihan Zhang; Ivan O Rosas; Michael H Cho; Jin-Ah Park; Peter J Castaldi; Fei Du; Xiaobo Zhou
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

4.  miR-21 Exerts Anti-proliferative and Pro-apoptotic Effects in LPS-induced WI-38 Cells via Directly Targeting TIMP3.

Authors:  Jin-Xiu Li; You Li; Tian Xia; Feng-Yan Rong
Journal:  Cell Biochem Biophys       Date:  2021-05-03       Impact factor: 2.194

5.  Senescence of IPF Lung Fibroblasts Disrupt Alveolar Epithelial Cell Proliferation and Promote Migration in Wound Healing.

Authors:  Kaj E C Blokland; David W Waters; Michael Schuliga; Jane Read; Simon D Pouwels; Christopher L Grainge; Jade Jaffar; Glen Westall; Steven E Mutsaers; Cecilia M Prêle; Janette K Burgess; Darryl A Knight
Journal:  Pharmaceutics       Date:  2020-04-24       Impact factor: 6.321

6.  Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Bing Wang; Wenmei Bai; Hongxia Ma; Fengsen Li
Journal:  Med Sci Monit       Date:  2021-01-02

7.  Comprehensive analysis of lncRNA-associated competing endogenous RNA network and immune infiltration in idiopathic pulmonary fibrosis.

Authors:  Zheng Wang; Shuoying Qu; Jie Zhu; Fengzhe Chen; Lixian Ma
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

8.  Curcumin protects murine lung mesenchymal stem cells from H2O2 by modulating the Akt/Nrf2/HO-1 pathway.

Authors:  Shiwen Ke; Yuanbing Zhang; Zhihui Lan; Shaofeng Li; Wei Zhu; Liangji Liu
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

9.  Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview.

Authors:  Li-Juan Li; Xuan Chen; Wen-Na Yang; Xiang-Mei Xu; Li-Ying Lu; Jie Wang; Yi-Xuan Kong; Jing-Hui Zheng
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.